Pharmaphorum’s digital magazine Deep Dive: Oncology outlines how adopting insights management technology has transformed how medical affairs oncology teams engage virtually. In this article, Within3 experts reveal the secrets of genuinely successful insights management for oncology.
When a global pandemic made virtual meetings a necessity, pharma adopted a more flexible, digitally-driven approach to stakeholder interaction – but the industry can still do more when it comes to making the most of its engagement strategies. The reason? Life science is characteristically conservative when it comes to implementing new technology.
“Pharma has been one of the last industries to move into digital,” says Natalie DiMambro, Vice President of Product Commercialization and Training at Within3. “Before COVID, these companies were still mostly doing meetings in-person, just because they’d been doing it that way for decades.”
The industry’s all-virtual emergency has passed, and most organizations have embraced a return to pre-pandemic interaction habits. But even at in-person events, insights still need to be collected, managed, analyzed and shared. Within a broader insights management strategy, asynchronous engagement enables teams to collect oncology insights before, during, and after face-to-face interactions for better recall and easier sharing and access.
As companies learn to use technology to augment and support in-person congress events, advisory boards, and other opportunities, they’ll consider challenges like data security, regulatory requirements, diversity, and the need to engage experts and patients worldwide. Download our idea guide to learn more about how teams can use technology to overcome some of the top oncology challenges in pharma.